Researchers have unveiled the first real look at a mitochondrial protein strongly linked to Parkinson's disease, revealing ...

Parkinson's cases are set to double by 2050. Learn why it's rising and how lifestyle changes can support long-term brain ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common. But a BBC investigation has highlighted ...

The prevalence of Parkinson disease was projected to be 267 cases per 100,000 in 2050, representing a 76% increase from 2021. (HealthDay News) — The prevalence of Parkinson disease is projected to ...

Musician Nenad Bach, who once played at Woodstock, ounded PingPongParkinson, a global movement helping those with Parkinson’s improve mobility, coordination, and social interaction. Now in 25 ...

WEHI researchers have made a huge leap forward in the fight against Parkinson's disease, solving a decades-long mystery that paves the way for development of new drugs to treat the condition.

Global Parkinson’s disease cases are projected to more than double to 25.2 million by 2050, driven largely by aging ...

The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a ...

Parkinson's Patients Have Improved Motor and Non-Motor Function After Treatment with Theralase(R) Cool Laser TherapyToronto, ...

The risk of developing Parkinson's disease is twice as high in men as in women, and new research points to a potential reason ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the ...